AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2012
Jun 5, 2012
30291_dirs_2012-06-05_8d6c6e38-4d64-4e1f-8da4-6de4b70ea7bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-06-04
Reporting Person: Posner Brian S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-04 | Common Stock | M | 2400 | $71.38 | Acquired | 15030 | Direct |
| 2012-06-04 | Common Stock | S | 2400 | $126.45 | Disposed | 12630 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-04 | Stock Option (Right to Buy) | $71.38 | M | 2400 | Disposed | 2018-07-22 | Common Stock (2400) | Direct |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6